Evidence map›Paper›PMID 34764492›Full record

ArticleNature biotechnology2022

Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data.

Duanchen Sun, Xiangnan Guan, Amy E Moran, Ling-Yun Wu, David Z Qian, Pepper Schedin, Mu-Shui Dai, Alexey V Danilov, Joshi J Alumkal, Andrew C Adey and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 334 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
334citing papers in PubMed, 1 pooled it
29.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

334 citing papers in PubMed, 1 synthesis or guideline pooled it, 489 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

274 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Duanchen SunComputational Biology Program, Oregon Health & Science University, Portland, OR, USA.
Xiangnan GuanComputational Biology Program, Oregon Health & Science University, Portland, OR, USA.
Amy E MoranDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0003-1952-7737
Ling-Yun WuAcademy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0000-0001-9487-0215
David Z QianKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Pepper SchedinDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0003-4244-987X
Mu-Shui DaiDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA.
Alexey V DanilovCity of Hope National Medical Center, Duarte, CA, USA.
Joshi J AlumkalDepartment of Internal Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
Andrew C AdeyKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0001-7648-8717
Paul T SpellmanComputational Biology Program, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-4810-0022
Zheng XiaComputational Biology Program, Oregon Health & Science University, Portland, OR, USA. xiaz@ohsu.edu.ORCID http://orcid.org/0000-0003-3364-8324
Oregon Health & Science University · USChinese Academy of Sciences · CNCity Of Hope National Medical Center · USUniversity of Michigan · US

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETER S NELSON · 2002 to 2026
$58.1M
Tissue/InformaticsP50CA186786 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ganesh S Palapattu · 2014 to 2026
$27.6M
NSAIDs During Postpartum Involution for Breast Cancer ChemopreventionR01CA169175 · NCI · UNIVERSITY OF COLORADO DENVER · PI SCHEDIN, PEPPER J · 2013 to 2024
$4.8M
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunctionR37CA263592 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Amy E Moran · 2021 to 2026
$3.2M
Defining the epigentic landscape at single cell resolutionR35GM124704 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ADEY, ANDREW · 2017 to 2021
$2.3M
Overcoming ibrutinib resistance in mantle cell lymphomaR01CA244576 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI DANILOV, ALEXEY V. · 2021 to 2025
$2.2M
Targeting Prostate Cancer Lineage Plasticity with BET Bromodomain InhibitionR01CA251245 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALUMKAL, JOSHI JAMES · 2020 to 2024
$1.9M
Adaptive resistance to HIF1a inhibition in hypoxiaR01CA207377 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI QIAN, ZHENG DAVID · 2016 to 2020
$1.8M
In Silico Screening of Alternative Polyadenylation Regulators in CancersK01LM012877 · NLM · OREGON HEALTH & SCIENCE UNIVERSITY · PI XIA, ZHENG · 2018 to 2020
$428k
HaemAPA: Characterizing alternative polyadenylation in human blood cellsR21HL145426 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI XIA, ZHENG · 2019 to 2020
$231k
NCI NIH HHS P50 CA097186NCI NIH HHS P50 CA186786NCI NIH HHS R01 CA169175NCI NIH HHS R01 CA207377NCI NIH HHS R01 CA244576NCI NIH HHS R01 CA251245NCI NIH HHS R37 CA263592NHLBI NIH HHS R21 HL145426NIGMS NIH HHS R35 GM124704NLM NIH HHS K01 LM012877
6 · The paper itself

Abstract

Single-cell RNA sequencing (scRNA-seq) distinguishes cell types, states and lineages within the context of heterogeneous tissues. However, current single-cell data cannot directly link cell clusters with specific phenotypes. Here we present Scissor, a method that identifies cell subpopulations from single-cell data that are associated with a given phenotype. Scissor integrates phenotype-associated bulk expression data and single-cell data by first quantifying the similarity between each single cell and each bulk sample. It then optimizes a regression model on the correlation matrix with the sample phenotype to identify relevant subpopulations. Applied to a lung cancer scRNA-seq dataset, Scissor identified subsets of cells associated with worse survival and with TP53 mutations. In melanoma, Scissor discerned a T cell subpopulation with low PDCD1/CTLA4 and high TCF7 expression associated with an immunotherapy response. Beyond cancer, Scissor was effective in interpreting facioscapulohumeral muscular dystrophy and Alzheimer's disease datasets. Scissor identifies biologically and clinically relevant cell subpopulations from single-cell assays by leveraging phenotype and bulk-omics datasets.

Indexed as

MelanomaSingle-Cell AnalysisGene Expression ProfilingHumansPhenotypeSequence Analysis, RNA

Identifiers

PMID34764492
PMCPMC9010342
OpenAlexW3211405363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.